Short-term and long-term vitamin C supplementation in humans dose-dependently increases the resistance of plasma to ex vivo lipid peroxidation.
D000328:Adult; D000975:Antioxidants / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects*; D008297:Male; D010949:Plasma / Q000187:drug effects*; D013438:Sulfhydryl Compounds / Q000097:blood; D013997:Time Factors; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000097:blood / Q000187:drug effects; D014527:Uric Acid / Q000097:blood; D024502:alpha-Tocopherol / Q000097:blood
D000975:Antioxidants; D013438:Sulfhydryl Compounds; D014451:Ubiquinone; D014527:Uric Acid; C026663:ubiquinol-10; D024502:alpha-Tocopherol; D001205:Ascorbic Acid